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Dr Till Bachmann’s laboratory is interested in 
diagnostics innovation in the context of targeted 
and effective antibiotic therapy. His research 
focuses on rapid point of care diagnostics to enable 
personalised approaches to medicine. This involves 
research on novel biosensors, molecular diagnostics, 
next generation sequencing and biomarkers as 
well as factors affecting the development and 
implementation of novel diagnostics. A major 
goal is to optimise antimicrobial therapy to reduce 
antimicrobial resistance and improve patient 
outcome in a wide range of diseases and healthcare 
settings.
Bachmann is currently Deputy Head of the 
Division of Infection and Pathway Medicine, Reader 
in Personalised Medicine in Infectious Diseases and 
Programme Director of the Clinical Microbiology 
& Infectious Diseases MSc at The University of 
Edinburgh, UK, as well as Programme Director 
of the Dual Award PhD in Integrated Biomedical 
Sciences at the Zhejiang University – University of 
Edinburgh Joint Institute in Haining, China. He has 
a PhD from biosensor research at the University 
of Stuttgart, Germany, and The University of 
Tokyo, Japan, as well as a German Habilitation 
in Analytical Biotechnology. In addition to his 
academic positions he has gained commercial 
experience as a founding CEO of Namaxx Genomic 
GmbH, Germany (2001–2006) and as Scientific 
Programme Director for MHC Scotland Ltd, UK 
(2013–2015). He also fulfils a variety of industrial 
and institutional advisory roles globally.
About the Research
Research at the Bachmann group covers three 
major themes: diagnostics research, antimicrobial 
resistance and global health. The diagnostics 
research theme explores novel molecular detection 
modalities, biomarkers and assay integration 
strategies.
Rapid diagnostics is essential for the investigation, 
treatment and management of infectious 
diseases. Research in this discipline requires an 
understanding of disease pathologies and systems 
interaction as well as an interdisciplinary approach 
involving biomedical sciences, chemistry, physics, 
engineering, data science and social science. 
Diagnostics innovation has exciting potential as a 
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method to counter the global threat of antimicrobial 
resistance.
One approach is to use antimicrobial susceptibility 
testing (AST) to ensure that suitable antibiotics 
are prescribed. AST can also be used to monitor 
pathogens and identify the emergence of resistant 
organisms within an infected patient. However 
current AST methods typically take between 
12 and 48 hours to produce results, too long 
for most clinical settings. Rapid testing, defined 
as results within an 8 h period, would allow 
results to be applied sooner and hence promote 
the optimised use of antimicrobials to prevent 
resistance developing. The development of rapid 
AST platforms is a complex process requiring 
intersectorial coordination between many 
stakeholders including industry, academia as well 
as the healthcare sector (1). 
In the Bachmann Lab low-cost carbon screen-
printed electrochemical sensors on ceramic 
substrates (2) as well as electrochemical 
methods to detect bacterial ribosomal RNA (3) 
and of genomic DNA extracted from methicillin-
resistant Staphylococcus aureus (MRSA) (4) are 
being developed. Electrochemical impedance 
spectroscopy (EIS) can be used with chemically 
functionalised microelectrode arrays aiming 
towards designing new tests which will produce 
highly sensitive results and rapid diagnosis times 
with minimal training for operators (Figure 1) 
(5, 6). 
In various collaborations, Bachmann looks 
at the development of novel microfluidic tools 
for biomedical applications. The growth of 
single- use components and disposable ‘lab on 
a chip’ technologies brings with it sustainability 
considerations. Recent work demonstrates laser 
worked poly(lactic acid) sheets as materials for 
such applications (7). Microfluidics have potential 
to improve detection of blood biomarkers at the 
point of care, where current techniques involve 
delays caused by the need for complex sample 
preparation (8). 
Current projects include novel materials for the 
preparation of electrodes for label-free molecular 
detection of antibiotic resistance; an electrochemical 
biosensor for the detection of bacterial quorum 
sensing compounds in respiratory diseases; project 
DOSA - Diagnostics for One Health and User Driven 
Solutions for antimicrobial resistance; and early 
diagnosis of drug-induced liver injury using point 
of care detection of microRNA, with funding from 
industry, the Medical Research Council (MRC), 
UK, the Economic and Social Research Council 
(ESRC), UK, the Joint Programming Initiative on 
Antimicrobial Resistance (JPIAMR) and charities.
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